FASEB conference on Hematological Malignancies

FASEB 血液恶性肿瘤会议

• 批准号: 6359970
• 负责人: CHI V. DANG
• 金额: $ 0.85万
• 依托单位: JOHNS HOPKINS UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2001
• 资助国家: 美国
• 起止时间: 2001-08-10 至 2002-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6359970
• 关键词: blood /lymphatic neoplasm; chromosome translocation; cytokine; functional /structural genomics; meeting /conference /symposium; neoplasm /cancer genetics; phosphorylation

DESCRIPTION (provided by applicant) This is an application for partial funding of a Conference on "Hematological Malignancies" being held under the auspices of the Federation of American Societies for Experimental Biology (FASEB) from July 28 to August 2, 2001 at Sno Mass, Colorado. There will be ten major sessions and four poster sessions. Participation will be limited to 155 scientist applicants who will be selected on the basis of their expertise and interests as most likely to contribute to a stimulating and productive environment. Among the topics to be included for discussion are: mechanisms of action of the products of chromosomal translocations, cytokine signaling and tyrosine phosphorylation in hematopoietic cells, aberrant transcriptional control, cell cycle alterations, deregulation of apoptotic, differentiation and mitogenic pathways in leukemias and lymphomas, genomics of hematological malignancies, stem cell biology, and translational research. The use of animal models systems to analyze the biological functions of genes implicated in the development of leukemias and lymphomas will be a key topic. A major purpose of the meeting is to bring together geneticists, biochemists, molecular biologists and clinicians. Hence, the conference will include a session on potential ways to utilize basic information towards the formulation of novel therapies. Analysis of the mechanisms underlying the development of hematopoietic neoplasms provides a unique opportunity for basic scientists with expertise in distinct areas of research to exchange ideas with clinicians who are familiar with the phenotypes associated with the various clinical disorders. From the information exchanged in this conference, new avenues of research have emerged from past conferences, and the development of novel therapeutic strategies in the treatment of hematopoietic malignancies are likely to emerge from future meetings.

描述（由申请人提供） 这是对“血液学”会议的部分资金的申请 恶意”在美国联合会的主持下举行 2001年7月28日至8月2日，实验生物学社会（FASEB） 科罗拉多州SNO Mass。 将有十个主要会议和四个海报 会议。 参与将仅限于155名科学家申请人 根据他们的专业知识和利益来选择 有助于刺激和生产的环境。 在主题中 包括： 染色体易位，细胞因子信号传导和酪氨酸磷酸化 造血细胞，异常转录控制，细胞周期改变， 白血病中凋亡，分化和有丝分裂途径的放松管制 和淋巴瘤，血液恶性肿瘤的基因组学，干细胞生物学和 翻译研究。 使用动物模型系统来分析 与白血病发展有关的基因的生物学功能 淋巴瘤将是一个关键主题。 会议的主要目的是带来 遗传学家，生物化学家，分子生物学家和临床医生在一起。 因此，会议将包括有关利用潜在方法的会议 新疗法的基本信息。 分析 造血肿瘤发展的基础机制提供了一种 具有专业知识的基础科学家在不同领域的专业知识的独特机会 研究以与熟悉的临床医生交流想法 与各种临床疾病相关的表型。 来自 在本次会议上交流的信息，研究的新途径已经出现 从过去的会议和新型治疗策略的发展 造血恶性肿瘤的治疗可能会从未来出现 会议。